AGP Executive Report
Last update: 8 hours agoAllergy Prevention Breakthrough: A large Australian study in JAMA Paediatrics found introducing eggs at 6–8 months can cut egg allergy risk by more than 17%, especially for babies with eczema. Medical Device Safety: The FDA issued a Class 2 recall for certain GE HealthCare fluoroscopy systems after an electrical shock risk tied to cable issues. AI Oversight: Research in JAMA Network Open says AI-enabled medical devices are more likely to be recalled when supporting clinical study information is missing, underscoring the need for stronger validation and postmarket monitoring. Cancer Imaging Funding: UCLA won a $3.2M NIH grant to advance specialized MRI approaches for detecting and treating glioblastoma. Weight-Loss Options: The UK MHRA approved the first GLP-1 tablet for weight loss (semaglutide/Wegovy), offering an oral alternative to injections. Public Health & Wellness: A new report highlights why sleep consistency may matter as much as sleep duration for long-term health. Food Label Crackdown (India): FSSAI served notices to eight food brands over misleading “healthy/organic/vegan/zero maida” claims. Healthcare Access (Philippines): Metro Pacific Health launched MPH OneCare, linking patients to specialist services across its hospital network. Pharma Manufacturing Trend: A report says AI in drug manufacturing is still mostly in pilot mode, with digital twins and real-time monitoring being tested to improve quality and reduce downtime.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![<![CDATA[What Do You See as The Next Phase of Obesity Innovation?]]>](https://cdn.sanity.io/images/0vv8moc6/pharmexec/96dee5a564196732c4e50d0fc28067e4d89acb0b-1280x720.jpg)
